Eli Lilly Ramps Up Foundayo Production to Meet Surging Demand for Oral GLP-1 Weight-Loss Pills
Eli Lilly is expanding manufacturing for its oral weight-loss drug Foundayo after CEO David Ricks revealed one-third of new GLP-1 pill patients are choosing the…